As of Jun 28
| -0.03 / -1.78%|
The 4 analysts offering 12-month price forecasts for Anthera Pharmaceuticals Inc have a median target of 2.13, with a high estimate of 4.00 and a low estimate of 2.00. The median estimate represents a +28.01% increase from the last price of 1.66.
The current consensus among 4 polled investment analysts is to Hold stock in Anthera Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.